Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases

NCT05647512 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped According to sponsor strategy

Conditions

Relapsed or Refractory Multiple Myeloma
Other Plasma Cell Diseases

Interventions

DRUG: LM-305
DRUG: Dexamethasone

Sponsor

LaNova Medicines Limited